
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Silgan Holdings Inc., manufactures and sells rigid packaging for consumer products in North America, Europe and internationally. The company is headquartered in Stamford, Connecticut.
| Revenue (TTM) | $6.58B |
| Gross Profit (TTM) | $1.14B |
| EBITDA | $978.36M |
| Operating Margin | 8.69% |
| Return on Equity | 12.90% |
| Return on Assets | 4.52% |
| Revenue/Share (TTM) | $61.93 |
| Book Value | $21.96 |
| Price-to-Book | 2.10 |
| Price-to-Sales (TTM) | 0.71 |
| EV/Revenue | 1.384 |
| EV/EBITDA | 9.92 |
| Quarterly Earnings Growth (YoY) | -5.20% |
| Quarterly Revenue Growth (YoY) | 6.50% |
| Shares Outstanding | $105.68M |
| Float | $88.44M |
| % Insiders | 16.31% |
| % Institutions | 91.37% |
Volatility is currently expanding

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Silgan (SLGN) reported earnings 30 days ago. What's next for the stock?

NORWALK, Conn.--(BUSINESS WIRE)--SILGAN DECLARES QUARTERLY DIVIDEND.

Although the revenue and EPS for Silgan (SLGN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Silgan Holdings (SLGN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.82 per share a year ago.

NORWALK, Conn.--(BUSINESS WIRE)--SILGAN ANNOUNCES FIRST QUARTER 2026 RESULTS.

AVY beats Q1 earnings estimates on strong volumes and cost control, with profits rising and cash flow swinging to positive despite mixed segment performance.

Silgan (SLGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

German medical packaging maker Gerresheimer has rejected a takeover bid from its U.S. rival Silgan , three sources familiar with the situation told Reuters.

Investors need to pay close attention to SLGN stock based on the movements in the options market lately.